SPECTRUM trial for squamous cell carcinoma of the head and neck

Bookmark and Share
Published: 31 Jan 2011
Views: 6120
Rating:
Save
Dr Marshall Posner - Mount Sinai School of Medicine, New York, USA

Dr Marshall Posner of the Mount Sinai School of Medicine, NY, talks to ecancertv at ESMO 2010 about various trials for head and neck cancer: The SPECTRUM trial, a phase 3 trial in 600 patients with recurrent and/or metastatic squamous cell carcinoma of the head and neck (SCCHN) receiving chemotherapy with or without panitumumab. Also pemetrexed plus cisplatin. He discusses the potential for increased quality of life and advantageous dosing schedules. Dr Posner also discusses his analysis of HPV positive and negative oropharynx patients: 'Five-year survival (OS) and patterns of failure for human papillomavirus (HPV) positive and negative oropharynx cancer (OPC) in the TAX 324 clinical trial.'